A cytochrome P450 enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as DEBRISOQUINE; ADRENERGIC RECEPTOR ANTAGONISTS; and TRICYCLIC ANTIDEPRESSANTS. This enzyme is deficient in up to 10 percent of the Caucasian population.
Cytochrome P 450 Cyp2d6 has been studied across 14 research domains including 🫁 Liver & Detox, 🧠 Focus & Attention, 🧠 Neuroprotection, 🔬 Oncology, 🌤️ Mood & Depression. The primary research focus is 🫁 Liver & Detox with 26% of studies addressing this area.
This evidence profile for Cytochrome P 450 Cyp2d6 is generated deterministically from 31 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.